Title Email Communications - Omicron and Breakthrough Cases (NIH/NIAID/Fauci) (National Institute of Allergy and Infectious Diseases (NIAID))
Completed
UserErin Marie Miller
AgencyNational Institute of Allergy and Infectious Diseases (NIAID)
JurisdictionUnited States of America
Updated01/27/2025
Submitted12/21/2021
Title Communications between the CDC and Montefiore Medical Center (National Institute of Allergy and Infectious Diseases (NIAID))
Fix Required
UserIndigo
AgencyNational Institute of Allergy and Infectious Diseases (NIAID)
JurisdictionUnited States of America
Updated02/04/2022
Submitted08/06/2021
Title Covid-19 Omicron Variant (Federal Data and Scientific Models) (National Institute of Allergy and Infectious Diseases (NIAID))
Withdrawn
UserErin Marie Miller
AgencyNational Institute of Allergy and Infectious Diseases (NIAID)
JurisdictionUnited States of America
Updated01/14/2022
Submitted12/21/2021
Title User Agency Jurisdiction Updated Submitted
Email Communications - Omicron and Breakthrough Cases (NIH/NIAID/Fauci) (National Institute of Allergy and Infectious Diseases (NIAID))
Completed
Erin Marie Miller National Institute of Allergy and Infectious Diseases (NIAID) United States of America 01/27/2025 12/21/2021
Communications between the CDC and Montefiore Medical Center (National Institute of Allergy and Infectious Diseases (NIAID))
Fix Required
Indigo National Institute of Allergy and Infectious Diseases (NIAID) United States of America 02/04/2022 08/06/2021
Covid-19 Omicron Variant (Federal Data and Scientific Models) (National Institute of Allergy and Infectious Diseases (NIAID))
Withdrawn
Erin Marie Miller National Institute of Allergy and Infectious Diseases (NIAID) United States of America 01/14/2022 12/21/2021